Product Details
Pediapharm Naproxen Suspension
Naproxen25 mg/mL
Oral Liquid
DIN/PIN/NPN
02162431
Manufacturer
Medexus Pharmaceuticals Inc.
Formulary Listing Date
1996-10-01
Unit Price
0.0949
Amount MOH Pays
0.0949
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Naproxen 25 mg/mL Oral Liquid: NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.
ATC Code
M01AE02